D-0363-2023 Class III Terminated

Recalled by SCA Pharmaceuticals — Windsor, CT

FDA drug recall D-0363-2023 was initiated by SCA Pharmaceuticals on February 24, 2023 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated June 21, 2023). Affected quantity: 2125 syringes.

Recall Details

Product Type
Drugs
Report Date
March 8, 2023
Initiation Date
February 24, 2023
Termination Date
June 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2125 syringes

Product Description

Fentanyl 1,500 mcg/30 mL syringe, Injection for Intravenous Use, Concentration = 50 mcg/mL, Preservative Free, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor CT 06095, NDC# 70004-0200-16.

Reason for Recall

Subpotent Drug

Distribution Pattern

Nationwide in the US.

Code Information

Lot # 1222043351, exp. date 03/29/2023 1222043387, exp. date 04/05/2023 1222043352, exp. date 04/05/2023 1222043463, exp. date 04/06/2023 1223043922, exp. date 05/04/2023